1887

Abstract

Here we describe a community-acquired pneumonia with , group A following a common cold caused by human metapneumovirus. The patient, a 58-year-old woman with no prior medical history, developed respiratory failure and multi-organ dysfunction caused by streptococcal toxic shock syndrome. The patient was admitted to the intensive care unit and treated with supportive care. The definitive diagnosis was made by BioFire FilmArray by Biomerieux (multiplex PCR) 12 h before positive blood culture, thus enabling the clinician to add clindamycin and intravenous immunoglobulin to the treatment. The patient was discharged fully recovered after 23 days. Streptococci group A is a rare pathogen of severe pneumonia and rapid diagnostics by syndromic testing, potentially performed in a near patient setting, is crucial for early implementation of targeted antimicrobial treatment.

Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000144
2020-06-17
2020-09-18
Loading full text...

Full text loading...

/deliver/fulltext/acmi/2/8/acmi000144.html?itemId=/content/journal/acmi/10.1099/acmi.0.000144&mimeType=html&fmt=ahah

References

  1. Tamayo E, Montes M, Vicente D, Pérez-trallero E. Streptococcus pyogenes pneumonia in adults : clinical presentation and molecular characterization of isolates 2006-2015; 2016; 281–13
  2. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1–7 [CrossRef][PubMed]
    [Google Scholar]
  3. Defining the group A streptococcal toxic shock syndrome Rationale and consensus definition. The Working group on severe streptococcal infections. JAMA 1993; 269:390–391[PubMed]
    [Google Scholar]
  4. Bartter T, Dascal A, Carroll K, Curley FJ. Toxic strep syndrome. A manifestation of group A streptococcal infection. Arch Intern Med 1988; 148:1421–1424 [CrossRef][PubMed]
    [Google Scholar]
  5. Parks T, Wilson C, Curtis N, Norrby-Teglund A, Sriskandan S. Polyspecific intravenous immunoglobulin in Clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis. Clin Infect Dis 2018; 67:1434–1436 [CrossRef][PubMed]
    [Google Scholar]
  6. Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S et al. Intravenouunous Imgloblin G therapy in streptococcal toxic shock syndrome. Clin Infect Dis 2003; 37:333–340
    [Google Scholar]
  7. Lecronier M, Elabbadi A, Mekontso Dessap A, de Prost N. Short and long-term outcomes of Streptococcus pyogenes pneumonia managed in the intensive care unit. Infect Dis 2017; 49:775–777 [CrossRef]
    [Google Scholar]
  8. Carapetis JR, Jacoby P, Carville K, Ang S-JJ, Curtis N et al. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group A streptococcal infections. Clin Infect Dis 2014; 59:358–365 [CrossRef][PubMed]
    [Google Scholar]
  9. Linnér A, Darenberg J, Sjölin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 2014; 59:851–857 [CrossRef][PubMed]
    [Google Scholar]
  10. Poole S, Clark TW. Rapid syndromic molecular testing in pneumonia: the current landscape and future potential. J Infect 2020; 80:1–7 [CrossRef][PubMed]
    [Google Scholar]
  11. Lee SH, Ruan S-Y, Pan S-C, Lee T-F, Chien J-Y et al. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J Microbiol Immunol Infect 2019; 52:920–928 [CrossRef][PubMed]
    [Google Scholar]
  12. Edin A, Eilers H, Allard A. Evaluation of the BioFire FilmArray pneumonia panel plus for lower respiratory tract infections. Infect Dis 2020; 52:1–10 [CrossRef][PubMed]
    [Google Scholar]
  13. Gadsby NJ, Russell CD, McHugh MP, Mark H, Conway Morris A et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016; 62:817–823 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000144
Loading
/content/journal/acmi/10.1099/acmi.0.000144
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error